Efficacy of nebulised versus intravenous tranexamic acid in management of non-massive haemoptysis: A randomised controlled trial

Introduction: Intravenous (IV) tranexamic acid (TXA), an antifibrinolytic agent, is routinely used in the treatment of non-massive haemoptysis. Topical TXA has shown haemostatic efficacy in surgical settings and epistaxis. Limited case reports have documented successful management of pulmonary bleed...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Vasudha Dinesh, T.P Elamurugan, Arun A. Mohanan, G. Vishnukanth
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wolters Kluwer Medknow Publications 2026-01-01
סדרה:	Lung India
נושאים:	intravenous tranexamic acid nebulised tranexamic acid non-massive haemoptysis
גישה מקוונת:	https://journals.lww.com/10.4103/lungindia.lungindia_264_25
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!